Episode 64
Biotech Hangout
00:00
The FDA Approves Sorepsis Gene Therapy
FDA approved Sorepsis gene therapy under accelerated approval. I think this is a win for the industry that the FDA, uh, and Peter marked his words to say he wants to support accelerated approval of gene therapy more. The big controversy here is they priced it at over $3 million in WAC. This is higher than the SMA drug that Novartis press that,. For a such a narrow label with a more scant data set, I think people will be scrutinizing this. It'll be interesting to watch how the commercial launch goes.
Transcript
Play full episode
